Despite that beat, management's guidance for 2025 was below Wall Street's estimates, disappointing investors. Illumina's sales guidance was for $4.34 billion at the midpoint. The analysts ...
Illumina (ILMN) is reducing its forecast for this year’s financial performance and cutting $100M in spending because China barred sales of its ...
Hosted on MSN2mon
Illumina Deal Sends 10x Genomics Stock TumblingAmid investor discontent, Wall Street activist Carl Icahn launched ... Investors seem to see the Fluent deal as a good sign for Illumina. In a note late Tuesday, Leerink Partners analyst Puneet ...
Wall Street analysts forecast that Illumina (ILMN) will report quarterly earnings of $0.91 per share in its upcoming release, pointing to a year-over-year increase of 550%. It is anticipated that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results